These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17387158)

  • 1. Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.
    Druilhe P; Brasseur P; Blanc C; Makler M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2112-6. PubMed ID: 17387158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
    Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL
    Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.
    Li J; Zhang J; Li Q; Hu Y; Ruan Y; Tao Z; Xia H; Qiao J; Meng L; Zeng W; Li C; He X; Zhao L; Siddiqui FA; Miao J; Yang Z; Fang Q; Cui L
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008255. PubMed ID: 32530913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo.
    Hamedi Y; Nateghpour M; Tan-ariya P; Tiensuwan M; Silachamroon U; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):512-8. PubMed ID: 12693585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
    Guthmann JP; Pittet A; Lesage A; Imwong M; Lindegardh N; Min Lwin M; Zaw T; Annerberg A; de Radiguès X; Nosten F
    Trop Med Int Health; 2008 Jan; 13(1):91-8. PubMed ID: 18291007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
    Basco LK; Marquet F; Makler MM; Le Bras J
    Exp Parasitol; 1995 Mar; 80(2):260-71. PubMed ID: 7895836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.
    Druilhe P; Moreno A; Blanc C; Brasseur PH; Jacquier P
    Am J Trop Med Hyg; 2001; 64(5-6):233-41. PubMed ID: 11463109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
    Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
    Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
    Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine-resistant Plasmodium vivax malaria in Peru.
    Ruebush TK; Zegarra J; Cairo J; Andersen EM; Green M; Pillai DR; Marquiño W; Huilca M; Arévalo E; Garcia C; Solary L; Kain KC
    Am J Trop Med Hyg; 2003 Nov; 69(5):548-52. PubMed ID: 14695094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
    Chehuan YF; Costa MR; Costa JS; Alecrim MG; Nogueira F; Silveira H; Brasil LW; Melo GC; Monteiro WM; Lacerda MV
    Malar J; 2013 Jul; 12():226. PubMed ID: 23819884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of in vitro drug sensitivity of antimalarials for Plasmodium falciparum using a colorimetric assay (DELI-microtest)].
    Brasseur P; Agnamey P; Moreno A; Druilhe P
    Med Trop (Mars); 2001; 61(6):545-7. PubMed ID: 11980406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.
    Kosaisavee V; Suwanarusk R; Nosten F; Kyle DE; Barrends M; Jones J; Price R; Russell B; Lek-Uthai U
    Exp Parasitol; 2006 Sep; 114(1):34-9. PubMed ID: 16545375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand.
    Lux D; Prajakwong S; Kollaritsch H; Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():50-4. PubMed ID: 15508781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
    Chotivanich K; Udomsangpetch R; Chierakul W; Newton PN; Ruangveerayuth R; Pukrittayakamee S; Looareesuwan S; White NJ
    Am J Trop Med Hyg; 2004 Apr; 70(4):395-7. PubMed ID: 15100453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
    Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia.
    Teka H; Petros B; Yamuah L; Tesfaye G; Elhassan I; Muchohi S; Kokwaro G; Aseffa A; Engers H
    Malar J; 2008 Oct; 7():220. PubMed ID: 18959774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ; Latour C; Lucas C; Colina O; Ringwald P; Picot S
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1172-8. PubMed ID: 17220424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.